Cover |
Feb. 11, 2025 |
|---|---|
| Cover [Abstract] | |
| Document Type | 8-K/A |
| Amendment Flag | true |
| Amendment Description | This Amendment No. 1 on Form 8-K/A (“Amendment No. 1”) amends the Current Report on Form 8-K of Adaptin Bio, Inc. (the “Company”), filed February 18, 2025 (the “Original Report”), in which the Company reported, among other events, the completion of the Merger (as defined in the Original Report). This Amendment No. 1 is being filed solely for the purpose of updating certain items in the Original Report under Item 2.01 and Item 9.01. This Amendment No. 1 does not amend any other item of the Original Report or purport to provide an update or a discussion of any developments at the Company or its subsidiaries subsequent to the filing date of the Original Report. The information previously reported in or filed with the Original Report is hereby incorporated by reference to this Form 8-K/A. Capitalized terms used but not defined herein have the meanings assigned to them in the Original Report. |
| Document Period End Date | Feb. 11, 2025 |
| Entity File Number | 000-56583 |
| Entity Registrant Name | ADAPTIN BIO, INC. |
| Entity Central Index Key | 0001938571 |
| Entity Tax Identification Number | 88-1566415 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 3540 Toringdon Way |
| Entity Address, Address Line Two | Suite 200 |
| Entity Address, Address Line Three | #250 |
| Entity Address, City or Town | Charlotte |
| Entity Address, State or Province | NC |
| Entity Address, Postal Zip Code | 28277 |
| City Area Code | 888 |
| Local Phone Number | 609-1498 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |